|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Investments at fair value (amortized cost of $6,322 and $13,174, respectively) | |||||||||
| Cash and cash equivalents | |||||||||
| Interest and dividend income receivable | |||||||||
| Principal receivable | |||||||||
| Receivable from related parties | |||||||||
| Unrealized appreciation of foreign currency forward contracts | |||||||||
| Prepaid expenses and other assets | |||||||||
| Total assets | |||||||||
| Liabilities | |||||||||
| Unrealized depreciation on foreign currency forward contracts | |||||||||
| Principal payable | |||||||||
| Accrued management fee | |||||||||
| Payable to related parties | |||||||||
| Accrued professional services fees | |||||||||
| Accounts payable, accrued expenses and other liabilities | |||||||||
| Total liabilities | |||||||||
| Net assets | |||||||||
| Components of Net Assets: | |||||||||
| Common shares, $0.001 par value, 1,000,000,000 shares authorized, 25,594,125 and 25,594,125 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | |||||||||
| Paid-in-capital in excess of par value | |||||||||
| Accumulated loss, net of distributions | |||||||||
| Net asset value per Common Share (NAV) |
Loading...
